pe
pep-05379 v1 CC-BY-SA-4.0

LCI anticancer peptide

A peptide studied in the lab for its potential to fight cancer cells; experimental, not yet an approved drug.

statuscomputed targetANTICANCER length47 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.785
avg pLDDT90.3
ranking score0.880
STRUCTURE · PEP-05379 × ANTICANCER
ranking0.880
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence47 aa
15101520253035404547
AIKLVQSPNGNFAASF VLDGTKWIFKSKYYDS SKGYWVGIYEVWDRK
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.8796475529670715 boltz-2
3-letter notation
Ala-Ile-Lys-Leu-Val-Gln-Ser-Pro-Asn-Gly-Asn-Phe-Ala-Ala-Ser-Phe-Val-Leu-Asp-Gly-Thr-Lys-Trp-Ile-Phe-Lys-Ser-Lys-Tyr-Tyr-Asp-Ser-Ser-Lys-Gly-Tyr-Trp-Val-Gly-Ile-Tyr-Glu-Val-Trp-Asp-Arg-Lys
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). LCI anticancer peptide (pep-05379, v1). PeptideModel. https://peptidemodel.com/card/pep-05379
@peptide{pep05379,
  sequence = {AIKLVQSPNGNFAASFVLDGTKWIFKSKYYDSSKGYWVGIYEVWDRK},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use